<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(4)</volume><submitter>Kwan RLY</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Ocular adnexal marginal zone lymphoma (OAMZL) is the most common subtype of primary ocular lymphoma and has been rising in incidence in Asian populations.&lt;h4>Methods&lt;/h4>We conducted a retrospective review of 95 patients diagnosed with OAMZL within a multi-ethnic cohort from Singapore. Clinical characteristics, survival outcomes including overall survival (OS) and progression-free survival (PFS), and maximum standardized uptake value (SUVmax) on staging F-18 fluorodeoxyglucose positron emission tomography/computed tomography (18-FDG-PET/CT) were investigated.&lt;h4>Results&lt;/h4>The cohort comprised 60 males and 35 females, with a median age of 58 years (25 - 88). Median follow-up was 92 months. The most common sites involved were the orbit (49.5%) and lacrimal gland (23.2%).</pubmed_abstract><journal>Journal of hematology</journal><pagination>223-233</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12404121</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical Patterns and Prognostic Outcomes of Asian Ocular Adnexal Marginal Zone Lymphoma.</pubmed_title><pmcid>PMC12404121</pmcid><pubmed_authors>Kwan RLY</pubmed_authors><pubmed_authors>Lim RMH</pubmed_authors><pubmed_authors>Chan JY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical Patterns and Prognostic Outcomes of Asian Ocular Adnexal Marginal Zone Lymphoma.</name><description>&lt;h4>Background&lt;/h4>Ocular adnexal marginal zone lymphoma (OAMZL) is the most common subtype of primary ocular lymphoma and has been rising in incidence in Asian populations.&lt;h4>Methods&lt;/h4>We conducted a retrospective review of 95 patients diagnosed with OAMZL within a multi-ethnic cohort from Singapore. Clinical characteristics, survival outcomes including overall survival (OS) and progression-free survival (PFS), and maximum standardized uptake value (SUVmax) on staging F-18 fluorodeoxyglucose positron emission tomography/computed tomography (18-FDG-PET/CT) were investigated.&lt;h4>Results&lt;/h4>The cohort comprised 60 males and 35 females, with a median age of 58 years (25 - 88). Median follow-up was 92 months. The most common sites involved were the orbit (49.5%) and lacrimal gland (23.2%).</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-29T21:29:32.953Z</modification><creation>2026-04-08T06:03:29.583Z</creation></dates><accession>S-EPMC12404121</accession><cross_references><pubmed>40904939</pubmed><doi>10.14740/jh2103</doi></cross_references></HashMap>